Medical specialists from France tagged as investigators in clinical trials studying Hereditary Angioedema

Total 9 results

Amandine Perier
Seen in:
- Niort, Centre Hospitalier Georges Renon
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Claire de Moreuil
Seen in:
- Brest Cedex, GSK Investigational Site
- Brest, CHU La Cavale Blanche
Trials:
- NCT05263934 (Principal Investigator)
- NCT01034969 (Principal Investigator)
Conditions:
- Eosinophilic Granulomatosis With Polyangiitis;
- Hereditary Angioedema (HAE)
David Launay, MD
Seen in:
- Lille, CHRU Lille
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Herve Maillard, MD
Seen in:
- Le Mans cedex 9, Centre Hospitalier Le Mans
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Laurence Bouillet, MD
Seen in:
- Grenoble, CHU de Grenoble
- Grenoble, University Hospital Michallon
Trials:
- NCT01034969 (Principal Investigator)
- NCT01808911 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE);
- Acquired Haemophilia
Ludovic Martin, MD
Seen in:
- Angers Cedex 10, Chu Angers
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Magali Aubineau, MD
Seen in:
- Lyon, Groupement Hospitalier Edouard Herriot
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Olivier Fain, MD
Seen in:
- Paris, Hopital Saint Antoine
Trials:
- NCT01034969 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE)
Pierre-Yves Jeandel, MD
Seen in:
- Nice, CHU de Nice Archet I
- Nice, Hospital Archet 1
Trials:
- NCT01034969 (Principal Investigator)
- NCT01808911 (Principal Investigator)
Conditions:
- Hereditary Angioedema (HAE);
- Acquired Haemophilia

Clinical Trials on Hereditary Angioedema

Pharvaris Netherlands B.V.

Active, not recruiting

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II (HAE CHAPTER-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
Pharvaris Netherlands B.V.

Completed

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (RAPIDe-1)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

Bulgaria, United States, Spain, Israel, Germany, Canada, Czechia, France, Hungary, Italy, Netherlands, Poland, United Kingdom
Pharvaris Netherlands B.V.

Recruiting

Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema (RAPIDe-3)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States
Pharvaris Netherlands B.V.

Recruiting

Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema (RAPIDe-2)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditions

United States, Bulgaria, Czechia, Hungary, Spain, France, Germany, Poland, Canada, Israel
CENTOGENE GmbH Rostock

Completed

Biomarker for Hereditary AngioEdema Disease (BioHAE)

Hereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | C1 Esterase Inhibitor Deficiency | HAE | Angio Edema | C4 Deficiency | Hereditary Angioedema Type III

Turkey, Armenia, Georgia, India, Peru, Poland, Romania
HAE Global Registry Foundation

Recruiting

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II (HGR)

Hereditary Angioedema Type I and II

Italy
KalVista Pharmaceuticals, Ltd.

Completed

A Phase II, Cross-over Clinical Trial Evaluating the Efficacy and Safety of KVD900 in the On-demand Treatment of Angioedema Attacks in Adult Subjects With Hereditary Angioedema Type I or II

Hereditary Angioedema

United States, Austria, Czechia, Germany, Hungary, Italy, Netherlands, North Macedonia, Poland, United Kingdom
Prothya Biosolutions

Completed

Kinetics, Efficacy and Safety of C1-Esteraseremmer-N

Hereditary Angioedema Type I | Angioneurotic Edema

Netherlands
Takeda

Not yet recruiting

A Study of Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

Hereditary Angioedema (HAE)
CSL Behring

Recruiting

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

Hereditary Angioedema (HAE)

United States, Israel

Medical specialists from France tagged as investigators in clinical trials studying Hereditary Angioedema

Clinical Trials on Hereditary Angioedema

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations